NOVAVAX AND SANOFI ANNOUNCE CO-EXCLUSIVE LICENSING AGREEMENT TO CO-COMMERCIALIZE COVID-19 VACCINE AND DEVELOP NOVEL COVID-19-INFLUENZA COMBINATION VACCINES

GAITHERSBURG, Md. -- The following information was released by Novavax, Inc.: Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 [...]